E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10...

  • Main
  • 2018 / 11
  • E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10...
Clinical Cancer Research 2018 / 11

E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High Dose Interferon-α2b in Advanced Melanoma

Tarhini, Ahmad A, Lee, Sandra J., Li, Xiaoxue, Rao, Uma N., Nagarajan, Arun, Albertini, Mark R, Mitchell, Jerry W., Wong, Stuart, Taylor, Mark A., Laudi, Noel, Truong, Phu V., Conry, Robert M, Kirkwoo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-2258
Date:
November, 2018
File:
PDF, 1.61 MB
english, 2018
Conversion to is in progress
Conversion to is failed